ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.

Br J Cancer · 2013 · PMC3669730 · PMID 23549037

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Concerning BRCA1, the positive patients showed a trend of better outcome than the negative ones.

also in 53,322 other papers

marginally statistically significantno p-value reported

Indeed, according to ERCC1 expression, a marginally statistically significant heterogeneity of the effect of treatment on response rate was observed.

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.